Literature DB >> 1392878

Withdrawal of a monopoly treatment.

L W Fleming, I S Henderson, M O Jones, W K Stewart.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1392878      PMCID： PMC1882728          DOI： 10.1136/bmj.305.6848.315

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Haemoglobin and serum iron responses to periodic intravenous iron-dextran infusions during maintenance haemodialysis.

Authors:  W K Stewart; L W Fleming; A M Shepherd
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  Poor response to treatment of renal anaemia with erythropoietin corrected by iron given intravenously.

Authors:  I C Macdougall; R D Hutton; I Cavill; G A Coles; J D Williams
Journal:  BMJ       Date:  1989-07-15

3.  Dextran antibodies, complement conversion and circulating immune complexes after intravenous iron dextran therapy in dialysed patients.

Authors:  L W Fleming; W K Stewart; D Parratt
Journal:  Nephrol Dial Transplant       Date:  1992       Impact factor: 5.992

4.  Bone marrow iron and plasma ferritin in dialysed patients given intravenous iron-dextran.

Authors:  L W Fleming; A K Saleem; H B Goodall; W K Stewart
Journal:  Clin Lab Haematol       Date:  1984
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.